Surprises lead to deceleration of overall Orthobio growth For Q419, US Orthobio market growth (comprised...
With a boost from an extra selling day during the third quarter, the US OrthoBio Market continues to be ...
SmartTRAK predicts Orthobiologic’s top market and technology trends to watch in 2019 At the beginning of...
Sales strategy, market reach and evidence-based medicine drives strong Orthobiologics performance SmartT...
Advanced, higher priced biologics push the US OrthoBio Market higher Based on Q418/FY18 SmartTRAK Financ...
Stem cell “secretome” is the latest advancement in regenerative medicine. Will it become the heart of ti...
Acquisitions and Partnerships are Highpoints in Q318 SmartTRAK reports that the US OrthoBio Market (comp...
Irrespective of Market Challenges, Orthobiologics Remain Strong While SmartTRAK saw a strong start in th...
Cerapedics’ CEO Glen Kashuba and President and COO Jeff Marx, Ph.D. discuss the future of the bone graft...
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global ortho...
Login